PriceTargets.com logo

AMN Healthcare Services - AMN Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $29.00
  • Forecasted Upside: -14.05%
  • Number of Analysts: 9
  • Breakdown:
  • 2 Sell Ratings
  • 3 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$33.74 As of 07/31/2026 04:59 PM ET
▼ -0.969 (-2.79%)

This chart shows the closing price for AMN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New AMN Healthcare Services Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMN

Analyst Price Target is $29.00
▼ -14.05% Downside Potential
This price target is based on 9 analysts offering 12 month price targets for AMN Healthcare Services in the last 3 months. The average price target is $29.00, with a high forecast of $40.00 and a low forecast of $18.00. The average price target represents a -14.05% upside from the last price of $33.74.

This chart shows the closing price for AMN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 9 contributing investment analysts is to hold stock in AMN Healthcare Services. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
2/7/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
5/8/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
8/6/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 3 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
2/2/2026
  • 1 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
5/3/2026
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
7/2/2026
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
8/1/2026

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/22/2026Truist FinancialBoost TargetBuy ➝ Buy$26.00 ➝ $40.00
6/23/2026CitigroupReiterated RatingMarket Outperform ➝ Market Outperform
6/23/2026Citizens JmpReiterated RatingMarket Outperform ➝ Market Outperform$36.00
6/17/2026Weiss RatingsUpgradeSell (E+) ➝ Sell (D-)
5/22/2026Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
5/20/2026Zacks ResearchDowngradeStrong-Buy ➝ Hold
5/13/2026UBS GroupBoost TargetNeutral ➝ Neutral$19.50 ➝ $32.00
5/11/2026BMO Capital MarketsBoost TargetOutperform ➝ Outperform$25.00 ➝ $26.00
5/11/2026Robert W. BairdBoost TargetNeutral ➝ Neutral$23.00 ➝ $26.00
5/8/2026Truist FinancialBoost TargetBuy ➝ Buy$24.00 ➝ $26.00
4/21/2026Zacks ResearchUpgradeHold ➝ Strong-Buy
2/23/2026CitigroupReiterated RatingOutperform ➝ Outperform
2/23/2026Citizens JmpBoost TargetMarket Outperform ➝ Market Outperform$22.00 ➝ $24.00
2/20/2026UBS GroupBoost TargetNeutral ➝ Neutral$19.00 ➝ $19.50
2/20/2026Robert W. BairdBoost TargetNeutral ➝ Neutral$21.00 ➝ $23.00
1/21/2026Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
1/15/2026JPMorgan Chase & Co.Set Target$25.00
1/15/2026BMO Capital MarketsBoost TargetOutperform ➝ Outperform$22.00 ➝ $25.00
12/19/2025CitigroupReiterated RatingMarket Outperform ➝ Market Outperform
12/19/2025Citizens JmpLower TargetMarket Outperform ➝ Market Outperform$24.00 ➝ $22.00
11/25/2025Zacks ResearchUpgradeStrong Sell ➝ Hold
11/7/2025UBS GroupBoost TargetNeutral ➝ Neutral$18.00 ➝ $20.50
11/7/2025Citizens JmpBoost TargetMarket Outperform ➝ Market Outperform$22.00 ➝ $24.00
10/27/2025Zacks ResearchDowngradeHold ➝ Strong Sell
10/13/2025Truist FinancialBoost TargetBuy ➝ Buy$20.00 ➝ $24.00
10/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/10/2025Bank of AmericaLower TargetUnderperform ➝ Underperform$20.00 ➝ $18.00
8/12/2025Citizens JmpLower TargetMarket Outperform ➝ Market Outperform$33.00 ➝ $22.00
8/11/2025BMO Capital MarketsLower TargetOutperform ➝ Outperform$27.00 ➝ $22.00
5/13/2025UBS GroupLower TargetNeutral ➝ Neutral$30.00 ➝ $25.50
4/15/2025Truist FinancialLower TargetBuy ➝ Buy$40.00 ➝ $25.00
2/24/2025BMO Capital MarketsLower TargetOutperform ➝ Outperform$38.00 ➝ $33.00
2/21/2025Truist FinancialLower TargetBuy ➝ Buy$47.00 ➝ $40.00
2/6/2025Citizens JmpReiterated RatingMarket Outperform ➝ Market Outperform$34.00 ➝ $34.00
11/13/2024Jefferies Financial GroupLower TargetHold ➝ Hold$41.00 ➝ $27.00
11/11/2024BMO Capital MarketsLower TargetOutperform ➝ Outperform$50.00 ➝ $46.00
11/8/2024Truist FinancialLower TargetBuy ➝ Buy$50.00 ➝ $47.00
11/8/2024William BlairDowngradeOutperform ➝ Market Perform
10/22/2024Citizens JmpLower TargetMarket Outperform ➝ Market Outperform$66.00 ➝ $57.00
10/21/2024Truist FinancialLower TargetBuy ➝ Buy$70.00 ➝ $50.00
10/7/2024Bank of AmericaDowngradeNeutral ➝ Underperform$65.00 ➝ $48.00
10/4/2024Citizens JmpReiterated RatingMarket Outperform ➝ Market Outperform$66.00 ➝ $66.00
10/2/2024BenchmarkReiterated RatingHold
8/13/2024Citizens JmpLower TargetMarket Outperform ➝ Market Outperform$75.00 ➝ $66.00
8/12/2024BMO Capital MarketsBoost TargetOutperform ➝ Outperform$60.00 ➝ $71.00
8/9/2024UBS GroupLower TargetNeutral ➝ Neutral$66.00 ➝ $65.00
5/28/2024BenchmarkReiterated RatingHold
5/15/2024Bank of AmericaBoost TargetNeutral ➝ Neutral$61.00 ➝ $65.00
5/13/2024BMO Capital MarketsLower TargetOutperform ➝ Outperform$80.00 ➝ $71.00
5/10/2024Citizens JmpReiterated RatingMarket Outperform ➝ Market Outperform$75.00
5/2/2024BenchmarkReiterated RatingHold
4/22/2024Truist FinancialLower TargetBuy ➝ Buy$88.00 ➝ $70.00
2/26/2024Citizens JmpLower TargetMarket Outperform ➝ Market Outperform$87.00 ➝ $75.00
2/20/2024BMO Capital MarketsLower TargetOutperform ➝ Outperform$85.00 ➝ $83.00
2/16/2024Citizens JmpLower TargetMarket Outperform ➝ Market Outperform$92.00 ➝ $87.00
12/6/2023Citizens JmpInitiated CoverageOutperform$85.00
12/5/2023Truist FinancialReiterated RatingBuy ➝ Buy$88.00
11/30/2023UBS GroupInitiated CoverageNeutral$73.00
11/6/2023Truist FinancialLower TargetBuy ➝ Buy$95.00 ➝ $88.00
11/3/2023BenchmarkDowngradeBuy ➝ Hold
11/3/2023Jefferies Financial GroupReiterated RatingBuy ➝ Hold$115.00 ➝ $70.00
8/7/2023BMO Capital MarketsLower TargetOutperform ➝ Outperform$114.00 ➝ $106.00
8/4/2023Truist FinancialBoost TargetBuy ➝ Buy$105.00 ➝ $110.00
8/4/2023Credit Suisse GroupLower TargetOutperform ➝ Outperform$115.00 ➝ $105.00
8/4/2023Bank of AmericaDowngradeBuy ➝ Neutral$112.00 ➝ $104.00
5/8/2023BMO Capital MarketsLower Target$100.00 ➝ $98.00
5/5/2023Credit Suisse GroupLower Target$128.00 ➝ $115.00
5/5/2023Robert W. BairdLower Target$111.00 ➝ $100.00
5/2/2023Truist FinancialLower Target$140.00 ➝ $105.00
4/3/2023Credit Suisse GroupLower TargetOutperform$147.00 ➝ $128.00
2/21/2023BMO Capital MarketsLower TargetOutperform$130.00 ➝ $109.00
2/17/2023Credit Suisse GroupReiterated RatingOutperform$147.00
2/17/2023Robert W. BairdLower TargetNeutral$134.00 ➝ $111.00
2/13/2023BenchmarkReiterated RatingBuy$148.00
11/7/2022BMO Capital MarketsBoost TargetOutperform$125.00 ➝ $130.00
11/4/2022BenchmarkBoost Target$140.00 ➝ $148.00
11/4/2022Truist FinancialBoost Target$130.00 ➝ $140.00
8/9/2022Credit Suisse GroupBoost Target$125.00
6/16/2022Credit Suisse GroupBoost TargetOutperform$120.00 ➝ $121.00
2/18/2022BenchmarkBoost TargetBuy$125.00 ➝ $140.00
2/18/2022Jefferies Financial GroupBoost TargetBuy$140.00 ➝ $170.00
11/17/2021Credit Suisse GroupBoost TargetOutperform$115.00 ➝ $139.00
11/8/2021BMO Capital MarketsBoost TargetOutperform$115.00 ➝ $127.00
8/31/2021Truist FinancialBoost TargetBuy$118.00 ➝ $130.00
8/10/2021Credit Suisse GroupBoost TargetOutperform$95.00 ➝ $115.00
8/9/2021BMO Capital MarketsBoost TargetOutperform$108.00 ➝ $115.00
(Data available from 8/1/2021 forward)

News Sentiment Rating

0.93 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/3/2026
  • 0 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2026
  • 1 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2026
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2026
  • 0 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2026
  • 2 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
6/2/2026
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2026
  • 12 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2026

Current Sentiment

  • 12 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

AMN Healthcare Services logo
AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.
Read More

Today's Range

Now: $33.74
Low: $33.34
High: $34.51

50 Day Range

MA: $31.99
Low: $27.24
High: $35.84

52 Week Range

Now: $33.74
Low: $14.86
High: $36.27

Volume

681,796 shs

Average Volume

733,874 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41

Frequently Asked Questions

What sell-side analysts currently cover shares of AMN Healthcare Services?

The following equities research analysts have issued research reports on AMN Healthcare Services in the last twelve months: Bank of America Corporation, BMO Capital Markets, Citigroup Inc., Citizens Jmp, JPMorgan Chase & Co., Robert W. Baird, Truist Financial Corporation, UBS Group AG, Wall Street Zen, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for AMN.

What is the current price target for AMN Healthcare Services?

0 Wall Street analysts have set twelve-month price targets for AMN Healthcare Services in the last year. Their average twelve-month price target is $29.00, suggesting a possible downside of 14.1%. Truist Financial Corporation has the highest price target set, predicting AMN will reach $40.00 in the next twelve months. Bank of America Corporation has the lowest price target set, forecasting a price of $18.00 for AMN Healthcare Services in the next year.
View the latest price targets for AMN.

What is the current consensus analyst rating for AMN Healthcare Services?

AMN Healthcare Services currently has 2 sell ratings, 3 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AMN, but not buy more shares or sell existing shares.
View the latest ratings for AMN.

What other companies compete with AMN Healthcare Services?

Other companies that are similar to AMN Healthcare Services include National Vision, Medpace, Veeva Systems, West Pharmaceutical Services and CorVel. Learn More about companies similar to AMN Healthcare Services.

How do I contact AMN Healthcare Services' investor relations team?

AMN Healthcare Services' physical mailing address is 8840 CYPRESS WATERS BOULEVARD SUITE 300, Dallas TX, 75019. The company's listed phone number is (866) 871-8519 and its investor relations email address is [email protected]. The official website for AMN Healthcare Services is www.amnhealthcare.com. Learn More about contacing AMN Healthcare Services investor relations.